The Clorox Company (NYSE:CLX) Shares Sold by Impax Asset Management Group plc

Impax Asset Management Group plc decreased its position in The Clorox Company (NYSE:CLX) by 5.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 47,779 shares of the company’s stock after selling 2,706 shares during the quarter. Impax Asset Management Group plc’s holdings in Clorox were worth $7,760,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Brooklyn Investment Group grew its position in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares in the last quarter. Prospera Private Wealth LLC acquired a new position in shares of Clorox in the 3rd quarter worth approximately $27,000. Continuum Advisory LLC grew its position in shares of Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares in the last quarter. Asset Planning Inc acquired a new position in shares of Clorox in the 4th quarter worth approximately $32,000. Finally, Catalyst Capital Advisors LLC acquired a new position in shares of Clorox in the 3rd quarter worth approximately $54,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Down 1.7 %

Shares of CLX stock opened at $154.52 on Tuesday. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The stock has a market cap of $19.03 billion, a PE ratio of 42.22, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42. The business’s fifty day moving average is $157.53 and its 200-day moving average is $160.03. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94.

Clorox (NYSE:CLX) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the business posted $2.16 EPS. Equities analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages recently issued reports on CLX. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and raised their price target for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. DA Davidson cut their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. Evercore ISI raised their price target on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. JPMorgan Chase & Co. raised their price target on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Finally, Wells Fargo & Company raised their price target on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 4th. Four equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, Clorox currently has a consensus rating of “Hold” and an average target price of $158.21.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.